Previous Close | 0.0570 |
Open | 0.0580 |
Bid | 0.0550 x N/A |
Ask | 0.0590 x N/A |
Day's Range | 0.0570 - 0.0580 |
52 Week Range | 0.0410 - 0.1800 |
Volume | |
Avg. Volume | 51,448 |
Market Cap | N/A |
Beta (5Y Monthly) | 0.75 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Emyria Ltd (ASX:EMD) CEO Michael Winlo sits down with Proactive’s Jonathan Jackson to discuss significant advancements in the company's mental health initiatives. Emyria recently opened the Empax C...
Emyria Ltd (ASX:EMD) managing director Michael Winlo runs Proactive through the company’s September quarter highlights. EMD generated $1,034,172 of clinical billings - an increase of more than 250%...
Emyria Ltd (ASX:EMD) MD Michael Winlo tells Proactive the company has secured an immediately available local supply of MDMA, the final component that allows patient dosing to commence for its MDMA-...